LCM
CRBP icon

Landscape Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Landscape Capital Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,726
Closed -$938K – 285
2020
Q2 		$938K Buy
+3,726
New +$753K 0.16% 133
2018
Q3 		– Sell
-513
Closed -$78K – 712
2018
Q2 		$78K Buy
+513
New +$93.2K 0.01% 510

Other funds holding CRBP

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Landscape Capital Management's CRBP Position: Q3 2020 in Review

Landscape Capital Management sold out of Corbus Pharmaceuticals (CRBP) in Q3 2020, closing a stake of 3,726 shares — an estimated $938K sold.

Landscape Capital Management first reported a position in CRBP in Q2 2018 and held it in 2 quarters. The position peaked at $938K in Q2 2020. 122 funds tracked by Wall St. Rank hold CRBP as of Q3 2020.

  • Landscape Capital Management reported no remaining Corbus Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Landscape Capital Management sold 3,726 Corbus Pharmaceuticals shares in Q3 2020, an estimated $938K.
  • Landscape Capital Management first reported a position in Corbus Pharmaceuticals in Q2 2018 and held it in 2 quarters.
  • Landscape Capital Management's Corbus Pharmaceuticals position peaked at $938K in Q2 2020.
  • 122 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2020.

Based on Landscape Capital Management's 13F filing for Q3 2020, filed 10 Nov 2020.